These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6576195)

  • 21. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ; Rosenbaum D
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of mouse natural killer activity by cyclosporin A.
    Yanagihara RH; Adler WH
    Immunology; 1982 Feb; 45(2):325-32. PubMed ID: 6460686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-induced changes in the susceptibility of murine and human lymphoma cells to natural cytotoxic lymphocytes.
    Giuliani-Bonmassar A; Graziani G; Frati L; Bonmassar E
    Int J Tissue React; 1984; 6(1):35-41. PubMed ID: 6585352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune regulation of the L5178Y murine tumor-dormant state. II. Interferon-gamma requires tumor necrosis factor to restrain tumor cell growth in peritoneal cell cultures from tumor-dormant mice.
    Suzuki Y; Liu CM; Chen LP; Ben-Nathan D; Wheelock EF
    J Immunol; 1987 Nov; 139(9):3146-52. PubMed ID: 3117888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
    Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K
    Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
    Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of NK cell activation by tumor cells on antigen-specific antibody responses.
    Koh CY; Yuan D
    J Immunol; 1997 Nov; 159(10):4745-52. PubMed ID: 9366398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma.
    Basham TY; Kaminski MS; Kitamura K; Levy R; Merigan TC
    J Immunol; 1986 Nov; 137(9):3019-24. PubMed ID: 3760580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumorigenicity of murine lymphomas selected through fluorescence-detected natural antibody binding.
    Tough DF; Chow DA
    Cancer Res; 1988 Jan; 48(2):270-5. PubMed ID: 3335005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer (NK) cells and interferon in Friend-virus-infected susceptible and resistant mice.
    Hertenstein B; Kreja L; Seidel HJ
    Exp Hematol; 1984 Aug; 12(7):603-9. PubMed ID: 6204881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antitumor effect of M-CSF and/or IFN-gamma gene cotransfected-macrophages by intratumoral injection].
    Lei H; Cao X; Yu Y
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):174-7. PubMed ID: 10920999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
    Rees RC; Reynolds CW; Herberman RB
    Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
    Zhang C; Tian Z; Hou G
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimetastatic effect of CpG DNA mediated by type I IFN.
    Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; Männel DN
    Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
    Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T
    Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.